Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase

Trine Zeeberg Iversen; Lotte Engell-Noerregaard; Eva Ellebaek; Rikke Andersen; Stine Kiaer Larsen; Jon Bjoern; Claus Zeyher; Cécile Gouttefangeas; Inger Birthe Mørck Thomsen; Bente Holm; Per Thor Straten; Anders Mellemgaard; Mads Hald Andersen; Inge Marie Svane

doi:10.1158/1078-0432.CCR-13-1560

Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase

Trine Zeeberg Iversen, Lotte Engell-Noerregaard, Eva Ellebaek, Rikke Andersen, Stine Kiaer Larsen, Jon Bjoern, Claus Zeyher, Cécile Gouttefangeas, Inger Birthe Mørck Thomsen, Bente Holm, Per Thor Straten, Anders Mellemgaard, Mads Hald Andersen, Inge Marie Svane

113 Citations (Scopus)

Abstract

To investigate targeting of indoleamine 2,3 dioxygenase (IDO) enzyme using a synthetic peptide vaccine administered to patients with metastatic non-small cell lung cancer (NSCLC).

Original language	English
Journal	Clinical Cancer Research
Volume	20
Issue number	1
Pages (from-to)	221-32
Number of pages	12
ISSN	1078-0432
DOIs	https://doi.org/10.1158/1078-0432.CCR-13-1560
Publication status	Published - 1 Jan 2014

Access to Document

10.1158/1078-0432.CCR-13-1560

Cite this

Iversen, T. Z., Engell-Noerregaard, L., Ellebaek, E., Andersen, R., Larsen, S. K., Bjoern, J., Zeyher, C., Gouttefangeas, C., Thomsen, I. B. M., Holm, B., Thor Straten, P., Mellemgaard, A., Andersen, M. H., & Svane, I. M. (2014). Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase. Clinical Cancer Research, 20(1), 221-32. https://doi.org/10.1158/1078-0432.CCR-13-1560

Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase. / Iversen, Trine Zeeberg ; Engell-Noerregaard, Lotte ; Ellebaek, Eva et al.
In: Clinical Cancer Research, Vol. 20, No. 1, 01.01.2014, p. 221-32.

Research output: Contribution to journal › Journal article › Research › peer-review

Iversen, TZ , Engell-Noerregaard, L , Ellebaek, E, Andersen, R, Larsen, SK, Bjoern, J, Zeyher, C, Gouttefangeas, C, Thomsen, IBM, Holm, B, Thor Straten, P, Mellemgaard, A, Andersen, MH & Svane, IM 2014, 'Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase', Clinical Cancer Research, vol. 20, no. 1, pp. 221-32. https://doi.org/10.1158/1078-0432.CCR-13-1560

@article{c7ad83a6083f42a0bd1425fd67889458,

title = "Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase",

abstract = "To investigate targeting of indoleamine 2,3 dioxygenase (IDO) enzyme using a synthetic peptide vaccine administered to patients with metastatic non-small cell lung cancer (NSCLC).",

author = "Iversen, \{Trine Zeeberg\} and Lotte Engell-Noerregaard and Eva Ellebaek and Rikke Andersen and Larsen, \{Stine Kiaer\} and Jon Bjoern and Claus Zeyher and C{\'e}cile Gouttefangeas and Thomsen, \{Inger Birthe M{\o}rck\} and Bente Holm and \{Thor Straten\}, Per and Anders Mellemgaard and Andersen, \{Mads Hald\} and Svane, \{Inge Marie\}",

year = "2014",

month = jan,

day = "1",

doi = "10.1158/1078-0432.CCR-13-1560",

language = "English",

volume = "20",

pages = "221--32",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "1",

}

TY - JOUR

T1 - Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase

AU - Iversen, Trine Zeeberg

AU - Engell-Noerregaard, Lotte

AU - Ellebaek, Eva

AU - Andersen, Rikke

AU - Larsen, Stine Kiaer

AU - Bjoern, Jon

AU - Zeyher, Claus

AU - Gouttefangeas, Cécile

AU - Thomsen, Inger Birthe Mørck

AU - Holm, Bente

AU - Thor Straten, Per

AU - Mellemgaard, Anders

AU - Andersen, Mads Hald

AU - Svane, Inge Marie

PY - 2014/1/1

Y1 - 2014/1/1

N2 - To investigate targeting of indoleamine 2,3 dioxygenase (IDO) enzyme using a synthetic peptide vaccine administered to patients with metastatic non-small cell lung cancer (NSCLC).

AB - To investigate targeting of indoleamine 2,3 dioxygenase (IDO) enzyme using a synthetic peptide vaccine administered to patients with metastatic non-small cell lung cancer (NSCLC).

UR - https://www.scopus.com/pages/publications/84892157282

U2 - 10.1158/1078-0432.CCR-13-1560

DO - 10.1158/1078-0432.CCR-13-1560

M3 - Journal article

C2 - 24218513

SN - 1078-0432

VL - 20

SP - 221

EP - 232

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 1

ER -

Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase

Abstract

Access to Document

Other files and links

Fingerprint

Cite this